[1] Lingling Y , Tianzhou W , Jiang L , et al. Bacterial infections in acute-on-chronic liver failure. Sem Liver Dis, 2018, 38(2):121-133.
[2] Zhao R , Wu W , Zhou Z , et al. Prognostic utility of novel biomarkers in acute-on-chronic liver failure (ACLF) associated with hepatitis B: A multicenter prospective study. Hepatol Res, 2019, 49(1):42.
[3] Shalimar, Rout G , Jadaun S S , et al. Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patients. Dig Liver Dis, 2018, 50(11):1221-1226.
[4] 李晨, 吕飒, 朱冰,等. 乙型肝炎病毒相关慢加急性肝衰竭患者近期预后危险因素的研究. 中华肝脏病杂志, 2016, 24(3):207-213.
[5] 王嘉鑫, 程娜, 向天新, 等. HBV相关慢加急性肝衰竭短期预后模型的建立及评价. 临床肝胆病杂志, 2019, 35(6):423-427.
[6] 汪徐林, 邵建国, 朱永昌, 等. 江苏省南通地区2005年至2014年慢加急性肝功能衰竭流行病学调查分析. 中华传染病杂志, 2016, 34(9):530-535.
[7] Chen J J , Huang J R , Yang Q , et al. Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China. Hepatobiliary Pancreat Dis Int, 2016, 15(3):275-281.
[8] Shi Y, Yang Y, Hu Y, et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology, 2015, 62(1):232-242.
[9] Chen E Q, Zeng F , Zhou L Y , et al. Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure. World J Gastroenterol,2015, 21(42):11964.
[10] Manchaagresti P, Castro C P D, Santos J S C D, et al. Recombinant invasive lactococcus lactis carrying a DNA vaccine coding the Ag85A antigen increases INF-γ, IL-6, and TNF-α cytokines after intranasal immunization. Front Microbiol,2017, 8:1263-1269.
[11] Yang Y , Jin Z , Dong R , et al. MicroRNA-29b/142-5p contribute to the pathogenesis of biliary atresia by regulating the IFN -γ gene. Cell Death Dis, 2018, 9(5):545.
[12] Zeng Z , Li L , Chen Y , et al. Interferon-γ facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance. J Exp Med, 2016, 32(4):20151218.
[13] Wang Y , Yu W , Shen C , et al. Predictive value of serum IFN-γ inducible protein-10 and IFN-γ/IL-4 ratio for liver fibrosis progression in CHB patients. Scient Rep, 2017, 7:40404.
[14] 中华医学会感染病学分会肝衰竭与人工肝学组;中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版).实用肝脏病杂志,2019,22(2):164-171.
[15] 张辉, 贾雷, 姚士伟, 等. MELD-Na评分对我国HBV相关慢加急性肝衰竭短期预后预测价值的Meta分析. 临床肝胆病杂志, 2018, 34(9):142-147.
[16] Xiaojing W , Xiaoping Z , Qin N . Immune-mediated liver failure. J Clin Hepatol, 2014, 30(10):1131-1144.
[17] 俞蕙, 朱启殚, 顾绍庆, 等. IFN-γ+874基因单核苷酸多态性与宫内HBV感染易感性关系的研究. 中华儿科杂志, 2004, 42(6):421-423.
[18] Budhu A , Wang X W . The role of cytokines in hepatocellular carcinoma. J Leukocyt Biol, 2006, 80(6):1197-1213.
[19] Shi Q , Cai C , Xu J , et al. Is there an association between IFN-γ +874A/T polymorphism and periodontitis susceptibility? A meta-analysis. Medicine, 2017, 96(25):e7288.
[20] Sun Y , Lu Y , Xie L , et al. Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population. Cancer Cell Int, 2015, 15(1):35. |